-
Select a region
-
Select language
Select language
Symkinet MR Methylphenidati hydrochloridum 10 mg, 20 mg, 30 mg, 40 mg
| Form: Modified-release capsule, hard | Size: 30 Modified-release capsules, hard |
Oral use 
Children 6 years and older Symkinet MR is used to treat ‘Attention Deficit Hyperactivity Disorder’ (ADHD).
• It is used in children and adolescents between the ages of 6 and 18, and in adults.
• It is used only after treatments which do not involve medicine, such as counselling and behavioural therapy, and which have been insufficient.
Symkinet MR is not for use as a treatment for ADHD in children under 6 years of age. It is not known if it is safe or of benefit in children under 6 years of age.
